While an alkaline diet may help reduce inflammation, a new study suggests that those who take certain medications for the problem may be receiving multiple health benefits.
Researchers from Stanfords School of Medicine wanted to conduct further research that the popular anti-inflammation drug known as Celecoxib can help prevent skin cancer after conducting research in mice helped prove the theory.
Dr. Jean Tang, who has previously conducted research on skin cancers, found that elderly men with high levels of vitamin D are less prone to the disease. Tang looked to use human test subjects to determine the effects of the drug on skin cancer.
“We wanted to see if we could have the same effect pharmacologically,” said Tang.
Previous research indicated that mice on the drug had a 70 percent decrease in skin cancer risk compared to mice on placebos.
Researchers found that participants taking the oral celecoxib were 50 percent less likely to develop skin cancer compared to the group on the placebo pills. Similarly, those who did develop cancer tumors experienced less severe cases.